Agoracom: Small Cap Investment - Resverlogix Corp. - Re: The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1

fuzzyjr

Dec 21, 2021 04:47PM

dlee38

Rank: Mail Room [?]

Points: 165 [?]

Votes: 3 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1

in response to

The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1

fuzzyjr

posted on Dec 21, 2021 08:42PM

Good news! If funding permitted, I call for a clinical trial on patients with diabetes assessing microvascular complications/diseases - retinopathy, nephropathy, neuropathy as (co- or composite) primary endpoints.

RE: COVID-19. Hope some of patients passed the screening. Not everyone gets passed screening phase so that could explain yet another / more delay.. what a surprise..

5 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply